Skip to main content
NGL Fine Chem Ltd. logo

NGL Fine Chem Ltd. — Investor Relations & Filings

Ticker · NGLFINE ISIN · INE887E01022 LEI · 335800X5TUU2OAV19X07 BSE.NS Manufacturing
Open in API
Filings indexed 309 across all filing types
Latest filing 2023-06-06 Regulatory Filings
Country IN India
Listing BSE.NS NGLFINE

About NGL Fine Chem Ltd.

https://www.nglfinechem.com

NGL Fine Chem Ltd. specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates for both veterinary and human healthcare sectors. The company focuses on high-quality chemical synthesis, producing a diverse range of products including anthelmintics, ectoparasiticides, and specialty chemicals. Key products in its portfolio include Nitroxynil, Closantel, Oxyclozanide, and Triclabendazole. Operating with Good Manufacturing Practice (GMP) standards, the firm serves a global clientele, providing customized manufacturing solutions and maintaining a strong emphasis on research and development to enhance process efficiency and product quality. Its technical expertise lies in complex chemical reactions and large-scale production of niche pharmaceutical components.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) providing information pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. It informs about the issuance of a 'Letter of Confirmation' to a shareholder in lieu of a lost share certificate. The content is a regulatory compliance announcement related to share certificate replacement, not a financial report, management change, or voting result. The document is short (1620 characters) and serves as a formal notification to the exchanges. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-06 English
Annual Secretarial Compliance Report
Regulatory Filings Classification · 95% confidence The document is titled 'Annual Secretarial Compliance Report for the year ended 31st March, 2023' and is issued pursuant to Regulation 24A of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. It is a detailed compliance report by a practicing company secretary reviewing statutory provisions and corporate governance compliance for the financial year ended March 31, 2023. The document includes references to various SEBI regulations and circulars, compliance status, and observations. It is not an Annual Report (10-K), nor an Earnings Release or Management Discussion and Analysis. It is a compliance report specifically related to secretarial and regulatory adherence, which fits the category of Regulatory Filings (RNS) as it is a regulatory compliance report and does not contain financial statements or management commentary typical of Annual or Interim Reports. The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement. Therefore, the best classification is Regulatory Filings (RNS).
2023-05-26 English
Reply to Clarification- Financial results
Annual Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors of NGL Fine-Chem Limited dated May 15, 2023. It includes the approval of audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2023, along with the statutory auditor's report. It also contains the statement of assets and liabilities as of March 31, 2023, dividend recommendation, notice of the upcoming Annual General Meeting (AGM), and appointments of auditors and scrutinizer. The document contains actual financial data, including revenue, expenses, profit, and balance sheet items, indicating it is a comprehensive financial report. The presence of audited financial results and detailed financial statements for the full fiscal year ending March 31, 2023, aligns with the characteristics of an Annual Report (10-K equivalent). Although it mentions the AGM and dividend, the primary content is the audited financial results and financial statements for the fiscal year, not just an announcement or summary. Therefore, the document should be classified as an Annual Report (10-K).
2023-05-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call held on May 19, 2023, discussing the financial results for the fourth quarter and year ended March 31, 2023. It includes detailed management commentary on financial performance, business outlook, product portfolio, and Q&A with analysts. The presence of a full transcript of the call, including moderator and participant dialogue, confirms it is a Call Transcript. The document is about 15,000 characters long, contains substantive discussion of financial results and outlook, and is not merely an announcement or summary. Therefore, the appropriate classification is Call Transcript (CT).
2023-05-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, informing about the company's participation in an investors conference call regarding the audited financial results for the quarter and year ended March 31, 2023. It mentions that the audio of the conference call has been uploaded on the company's website. The document itself is a notification about the conference call event, not the transcript or the financial results report. The document length is short (1572 characters), and it serves as an announcement rather than the full transcript or detailed financial data. Therefore, the document is best classified as a Call Transcript (CT) related announcement, but since it does not contain the transcript itself, it is a Regulatory Filing (RNS) as a disclosure notice about the call.
2023-05-19 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is an investor presentation for the 4th quarter and full fiscal year ended March 31, 2023, as explicitly stated in the letter to the stock exchanges and the title of the document. It contains detailed financial data including quarterly and full-year operational metrics, segmental revenue mix, geographic mix, product and customer concentration, profit and loss summary, balance sheet summary, and cash flow statement. It also includes management commentary and strategic overview sections. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full investor presentation rather than a brief announcement or a regulatory filing. Therefore, the appropriate classification is Investor Presentation (IP).
2023-05-18 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.